Rachel G. Williams

Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology

T. Vogt, G. Mcallister, C. Dominguez, 2022, Journal of medicinal chemistry.

Enantioselective Synthesis of Cyclopropanone Equivalents and Application to the Formation of Chiral β-Lactams.

V. Lindsay, Yujin Jang, Rachel G. Williams, 2020, Angewandte Chemie.

Enantioselective Synthesis of Cyclopropanone Equivalents and Application to the Formation of Chiral β‐Lactams

V. Lindsay, Yujin Jang, Rachel G. Williams, 2020, Angewandte Chemie.

Enantioselective Synthesis of Cyclopropanone Equivalents and Application to the Synthesis of β-Lactams

V. Lindsay, Yujin Jang, Rachel G. Williams, 2019 .

Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease.

G. Mcallister, C. Dominguez, V. Beaumont, 2021, ACS medicinal chemistry letters.

Evaluation of 5 ‑ (Tri fl uoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington ’ s Disease

G. Mcallister, C. Dominguez, V. Beaumont, 2021 .